Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia.

Bankar, Aniket

Novel L-nucleoside analogue, 5-fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia. [electronic resource] - Haematologica 02 2021 - 574-579 p. digital

Publication Type: Letter; Research Support, Non-U.S. Gov't

1592-8721

10.3324/haematol.2019.226795 doi


Cytarabine
Humans
Leukemia, Myeloid, Acute--drug therapy
Nucleosides